A total of 66 women with IR and nodular hyperplasia , diagnosed by fine needle aspiration biopsy ( FNAB ) , who completed this prospective 6-month duration protocol , were assigned to one of four groups : Group I ( GI ) ( n = 14 ) , patients treated with M ; GII ( n = 18 ) , patients treated with M plus L-T ; GIII ( n = 19 ) , patients treated with L-T ; and GIV ( n = 15 ) , patients without any treatment .
